Author:
McKenna K. F.,Baker G. B.,Coutts R. T.,Rauw G.,Mozayani A.,Danielson T. J.
Reference13 articles.
1. Baker GB, Coutts RT, Rao TS (1987) Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br J Pharmacol 92:243–255.
2. Baker GB, Coutts RT (1989) Metabolism of monoamine oxidase inhibitors. Proc West Pharmacol Soc 25:417–420.
3. Danielson TJ, Coutts RT, Baker GB, Chan MC (1988) Potential prodrugs of phenelzine: N2-ethoxycarbonylphenelzine. J Pharmacol Sci 77:498–499.
4. Dyck LE, Durden DA, Boulton AA (1985) Formation of β-phenylethylamine from the antidepressant, β-phenylethylhydrazine. Biochem Pharm 34:1925–1929.
5. Freeman JJ, Sulser F (1972) Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action. J Pharmacol Exp Ther 183:307–315.